The Korean-based stem cell biotech, RNL Bio, which also does business in the U.S. as RNL Bio and Human Biostar Inc, reportedly (seems to be a press release, PR) has filed an investigational new drug (IND) application with the Korean FDA (KFDA). The purpose of the application is to test the efficacy of autologous adult stem cells […]
In previous years I’ve done yearly predictions for the coming year’s events in the stem cell world (see predictions for 2011 and 2012 predictions). I did pretty well in my predicting stem cell events for this year (see analysis here) scoring a respectable 70%. Isn’t that a C-?,you might ask. No, when it comes to
My stem cell predictions for 2013 Read More »
Every year around this time I put my “best of” the year in stem cells including awards such as my Stem Cell Person of the Year Award. For example here are the 2011 awards. This year I’m also trying with difficult to decide on what was the craziest thing for stem cells that happened in
What was the strangest event for stem cells in 2012? Pick from top 5 in poll Read More »
Today, a judge issued a complex, temporary restraining order (PDF here, provided by Celltex) regarding Texas stem cell company Celltex and Human Biostar Inc (HBI)/Biostar, former partners who are now in conflict and have sued each other. For more background see here, here, and here. Note that while both parties have sued each other, the judge’s ruling
A scientist named Dr. Rongxiang Xu has, according to the newspaper The Australian, sued the Nobel Prize Committee for giving the award to Yamanaka and Gurdon and not him. Xu is quoted in the article that he “discovered ‘regenerative cells’ in 1984. The suit filed in S. California, alleges libel and unfair competition. The Australian
Chinese scientist sues Nobel Committee for defamation over awards to Yamanaka and Gurdon Read More »
Celltex is a stem cell company in Texas most well known for Guv Rick Perry’s stem cell transplant. The Celltex business model is to isolate, amplify, and bank patients’ stem cells for subsequent treatment by physicians (for more background including on the FDA role see here and here). Until the last few weeks, an important element
Celltex and former partner RNL Bio/Biostar sue each other: what’s going on? Read More »
It was near to a stem cell wonk’s heaven to be in the audience for a panel discussion, entitled Understanding the Legal and Policy Challenges to Stem Cell Research, here at the World Stem Cell summit in Florida late this afternoon. The stellar panel included Jeanne Loring of Scripps, Beth Roxland of Hofstra University and formerly of
WSCS2012: outstanding panel discussion on legal challenges to stem cell research Read More »
Courthouse News Service is reporting that Texas stem cell company Celltex is being sued by Biostar/RNLBio. This is big news as RNLBio was running the Celltex clinic to expand stem cells. Assuming the Courthouse News report is accurate, it suggests that Celltex and their key partner are in the middle of a potentially ugly breakup.
Celltex & RNLBio/Biostar: breaking up is hard to do? Read More »
There is enormous interest in point-of-care for-profit stem cell commercialization by relatively small clinics hoping to hit it big here in the U.S. Some big investors have poured millions into these clinics that are treating patients with adult stem cell therapies. As I’ve talked with some of these folks they expect this market to grow dramatically
Surprising main obstacle to point-of-care stem cell commercialization by small clinics Read More »
Today the US Federal Court of Appeals via a 3-judge panel ruled in favor of continued NIH funding of human embryonic stem cell research (hESCR). The ruling is a setback for pro-life extremists trying to shut down a very promising avenue of stem cell-based regenerative medicine with their lawsuit. It’s a good day for the
Analysis: what does the federal court embryonic ruling really mean & what’s next? Read More »